domingo, 29 de junio de 2014

JAMA Network | JAMA Internal Medicine | Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues:  Meta-analysis of Randomized Clinical Trials

JAMA Network | JAMA Internal Medicine | Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues:  Meta-analysis of Randomized Clinical Trials





Genomics & Health Impact Update



Evidence-based Pharmacogenomics:

two researchers
Genotype-guided vs clinical dosing of warfarin and its analoguesExternal Web Site Icon
Stergiopoulos K, et al. JAMA Intern Med. June 16, 2014
FDA table of pharmacogenomic markersExternal Web Site Icon includes drugs with genomic information in their labeling. The labeling for some, but not all, of the products includes specific actions to be taken based on the biomarker information.
CDC paper: Prioritizing genomic applications for action by level of evidence: a horizon-scanning methodExternal Web Site Icon.  Dotson WD, et al. Clin Pharmacol Ther. 2014 Apr;95(4):394-402.

No hay comentarios:

Publicar un comentario